Spotlight On: Biosimilar Litigations – August 2024

Start
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. Litigations relating to disputes between two reference product sponsors, or non-practicing entities/universities and reference product sponsors are not included. Litigations related solely to manufacturing…
By: Venable LLP
Previous Story

Governor Pritzker Signs Amendment Limiting Damages To A Single Recovery

Next Story

The Risks of Unregulated Regenerative Medicine